+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
ID07267000

Impact of 12-Week Moderate or High-Intensity Exercise on Immune Response in Lung Cancer Patients

Led by Medical University of Graz · Updated on 2026-06-09

50

Participants Needed

1

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects of a 12-week exercise training program on patients with non-small cell and small-cell lung cancer. Lung cancer is a leading cause of cancer deaths worldwide, and while exercise is known to lower the risk of some cancers and improve immune response, its role as part of routine lung cancer treatment remains unclear. This study aims to compare moderate-intensity continuous exercise MICE, high-intensity interval exercise HIIT, and standard exercise recommendations to understand their impact on immune system markers and physical health in lung cancer patients. Participants will be randomly assigned to one of three groups one group will perform supervised moderate-intensity continuous exercise twice a week plus home walking five times a week another group will do supervised high-intensity interval exercise twice weekly plus the same home walking and a control group will receive general exercise advice without supervised sessions or home walking requirements. The exercise programs follow a defined frequency, intensity, type, and time F.I.T.T. principle, with medical supervision during sessions. Throughout the study, participants will have blood samples taken to analyze immune cell characteristics and cytokine profiles using advanced techniques like FACS analysis, mitochondrial function testing, and lipid profiling. The study will also assess aerobic capacity, quality of life using validated questionnaires, and body composition before and after the 12-week intervention. These measurements will help evaluate how exercise might influence the immune response and overall well-being during lung cancer treatment.

CONDITIONS

Brief Title

EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER

Research Team

L

Lukas Spielbüchler, MEd, BEd

E

Emine Betül Deniz, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here